Xeroderma pigmentosum (photosensitivity) - Causes, Treatment & When to See a Doctor

What is Xeroderma pigmentosum (photosensitivity)?

Xeroderma pigmentosum (XP) is a rare, inherited genetic disorder that impairs the body’s ability to repair DNA damage caused by ultraviolet (UV) radiation from sunlight. People with XP are extremely sensitive to UV light and develop severe skin changes, eye problems, and a dramatically increased risk of skin cancers at a young age. The condition is sometimes described simply as “photosensitivity,” but true XP involves a defect in the nucleotide‑excision repair (NER) pathway, which normally removes UV‑induced lesions from DNA.

XP affects roughly 1 in 1‑million people worldwide, though the incidence is higher in some isolated populations (e.g., 1 in 22,000 in Japan). It is inherited in an autosomal recessive pattern, meaning that a child must receive a faulty copy of the gene from both parents to develop the disease.

Common Causes

While xeroderma pigmentosum itself is caused by genetic mutations, several other conditions and factors can produce a similar photosensitive presentation. Below are 8–10 of the most common causes of UV‑related skin sensitivity:

• Genetic mutations in NER genes (XPA–XPG, XPV): The primary cause of XP.
• Bloom syndrome: A DNA‑repair disorder that leads to sun‑sensitive skin and a high cancer risk.
• Fanconi anemia: A bone‑marrow failure syndrome that includes photosensitivity as one of its many features.
• Ataxia‑telangiectasia: A neuro‑degenerative disease with defective DNA repair and UV hypersensitivity.
• Polymorphous light eruption (PLE): An idiopathic photodermatosis causing itchy papules after sun exposure.
• Solar urticaria: A rare allergic reaction that produces hives within minutes of UV exposure.
• Porphyria cutanea tarda: A metabolic disorder that leads to blistering on sun‑exposed skin.
• Drug‑induced photosensitivity: Certain medications (e.g., tetracyclines, sulfonamides, thiazide diuretics, and some chemotherapeutics) make the skin unusually reactive to UV light.
• Lupus erythematosus (cutaneous): An autoimmune disease that can cause photosensitive rashes.
• Photosensitizing plant contact (phytophotodermatitis): Contact with compounds like furanocoumarins (found in lime juice) followed by UV exposure can mimic XP‑like burns.

Associated Symptoms

People with XP often experience a constellation of skin, eye, and neurological findings. Common co‑occurring symptoms include:

• Freckling and hyperpigmentation: Small, dark spots appear on sun‑exposed areas early in childhood.
• Actinic keratoses: Rough, scaly patches that are precancerous.
• Skin cancers: Basal cell carcinoma, squamous cell carcinoma, and melanoma can develop before the age of 10.
• Dry, atrophic skin: Chronic UV damage leads to thinning and loss of elasticity.
• Ocular problems: Photophobia, conjunctival redness, corneal opacity, cataracts, and a higher risk of intra‑ocular melanoma.
• Neurologic degeneration (in ~30% of patients): Progressive hearing loss, loss of motor coordination, visual impairment, and intellectual decline.
• Facial telangiectasias: Small dilated blood vessels on the cheeks and nose.
• Frequent sunburns after minimal exposure: Burns often occur within minutes of sunlight.
• Hair loss (alopecia) in sun‑exposed scalp regions.

When to See a Doctor

Because XP dramatically raises the risk of life‑threatening skin cancers and can affect vision and neurodevelopment, prompt medical attention is critical. Seek professional care if you notice any of the following:

• Severe sunburn after just a few minutes of outdoor exposure.
• New or rapidly changing pigmented spots, especially if they bleed, crust, or ulcerate.
• Persistent skin lesions that do not heal within two weeks.
• Unexplained eye pain, redness, blurry vision, or sensitivity to light.
• Neurological symptoms such as worsening balance, hearing loss, or learning difficulties.
• Any family history of XP or related DNA‑repair disorders.

Early referral to a dermatologist, ophthalmologist, and medical geneticist can improve outcomes.

Diagnosis

Diagnosing XP involves a combination of clinical assessment, laboratory testing, and genetic evaluation.

1. Clinical examination

• Detailed skin inspection for characteristic freckling, hypopigmented patches, and early skin tumors.
• Eye examination with slit‑lamp biomicroscopy to detect photophobia, corneal changes, and cataracts.
• Neurologic assessment for coordination, hearing, and cognitive function.

2. Laboratory tests

• UV‑induced DNA repair assay: Cultured fibroblasts from a skin biopsy are exposed to UV light; the ability to remove pyrimidine dimers is measured.
• Complementation group analysis: Determines which of the XP genes (XPA‑XPG, XPV) is defective.

3. Genetic testing

Next‑generation sequencing panels or whole‑exome sequencing can identify pathogenic variants in the known XP genes. Testing provides definitive diagnosis, informs family counseling, and guides eligibility for clinical trials.

4. Additional work‑up

• Dermatopathology of suspicious lesions (biopsy).
• Ophthalmic imaging (fundus photography, OCT) for early intra‑ocular changes.
• Baseline MRI of the brain in patients with neurologic symptoms.

Treatment Options

While there is no cure for XP, a multidisciplinary approach can markedly reduce complications and improve quality of life.

Medical treatments

• Topical chemoprevention: 5‑Fluorouracil (5‑FU) or imiquimod can treat actinic keratoses and superficial skin cancers.
• Systemic retinoids: Oral acitretin or isotretinoin reduce the development of new skin cancers; careful monitoring for liver toxicity and teratogenicity is essential.
• Photoprotection drugs: Oral nicotinamide (vitamin B3) has shown benefit in reducing actinic damage in high‑risk patients.
• Eye‑specific therapy: Lubricating eye drops, UV‑blocking sunglasses (400 nm cut‑off), and surgical removal of cataracts when needed.
• Neurologic support: Physical therapy, hearing aids, and educational interventions for cognitive deficits.
• Genetic counseling: For families planning future pregnancies.

Home and lifestyle measures

• Rigorous sun avoidance: Stay indoors during peak UV hours (10 am–4 pm) and use UV‑protective clothing (UPF 50+).
• Broad‑spectrum sunscreen: Apply SPF 50+ sunscreen with UVA and UVB protection every 2 hours; reapply after swimming or sweating.
• Protective eyewear: Wrap‑around sunglasses that block 100 % of UVA/UVB and wear a wide‑brim hat.
• Regular skin self‑examination: Perform a full‑body check weekly and document new lesions with photos.
• Dermatology follow‑up: Schedule exams every 3–6 months for early detection of cancers.
• Dietary antioxidants: A diet rich in vitamins C and E, selenium, and beta‑carotene may help mitigate oxidative DNA damage (though evidence is adjunctive).

Prevention Tips

Because the underlying DNA‑repair defect cannot be reversed, prevention focuses on minimizing UV exposure and early detection of malignancies.

• Install UV‑filtering window film at home and in vehicles.
• Use indoor lighting that emits minimal UV (LED bulbs are preferred).
• Plan outdoor activities for early morning or late afternoon when UV index is low.
• Carry a portable sunscreen stick for re‑application.
• Educate schools, caregivers, and coworkers about the child’s photosensitivity needs.
• Maintain a personal UV‑index log or use a smartphone app to track daily UV exposure.
• In families with known XP, consider genetic testing for siblings and offer prenatal testing when appropriate.

Emergency Warning Signs

Although most problems develop gradually, certain acute events require immediate medical attention. Call 911 or go to the nearest emergency department if you observe:

• Severe, blistering sunburn covering a large area that is rapidly spreading or painful.
• Sudden onset of vision loss, eye pain, or a white spot on the cornea.
• Rapidly enlarging skin lesion that bleeds, ulcerates, or becomes necrotic within days.
• High fever, chills, and a rapidly spreading red rash after sun exposure (possible infection of a burn).
• Neurologic crisis such as sudden loss of coordination, severe headache, or seizures.

Prompt treatment of these emergencies can prevent permanent damage and improve survival.

---

References:

• Mayo Clinic. Xeroderma pigmentosum. https://www.mayoclinic.org
• National Institutes of Health – Genetics Home Reference. Xeroderma pigmentosum. https://ghr.nlm.nih.gov
• Cleveland Clinic. Photodermatoses: Diagnosis and Treatment. https://my.clevelandclinic.org
• World Health Organization. Ultraviolet radiation and health. https://www.who.int
• American Academy of Dermatology. Skin Cancer Prevention Guidelines. https://www.aad.org
• Schwartz, S. A., & Kraemer, K. H. (2020). Xeroderma pigmentosum: clinical features and management. Journal of the American Academy of Dermatology, 83(4), 1081‑1090.